The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment
International Journal of Methods in Psychiatric Research · 2025
DOI: 10.1002/mpr.70037 ↗At a glance
Validierungsstudie in International Journal of Methods in Psychiatric Research, 2025. Written by Ezgi Ince Guliyev and 9 co-authors. Institution: Department of Psychiatry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye. Major MEDLINE topics: Bipolar Disorder, Psychometrics, Cognitive Dysfunction, Psychiatric Status Rating Scales. 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objectives
The Cognitive Complaints Rating Scale in Bipolar Disorder (COBRA) is a brief self‐report measure designed to capture Subjective Cognitive Complaints (SCC) experienced by patients with Bipolar Disorder (BD). This study aimed to translate the 16‐item COBRA into Turkish (COBRA‐TR) and comprehensively assess its psychometric properties.
Methods
We recruited 160 participants, consisting of 80 BD patients in remission and 80 controls. The psychometric evaluation included confirmatory factor analysis (CFA), calculation of internal consistency, and examination of divergent and convergent validity through Pearson's correlations with related scales. Statistical analyses were performed using the SPSSv29 and the Jamovi software of R Statistical Package.
Results
The COBRA‐TR showed excellent internal consistency (Cronbach α = 0.898) and robust convergent validity, strongly correlating with the Cognitive Failures Questionnaire ( r = 0.784; p < 0.001). It demonstrated moderate‐to‐high correlations with cognitive ( r = 0.574; p < 0.001) and global functioning ( r = 0.624; p < 0.001), as assessed by the Functioning Assessment Short Test. CFA provided strong support for a unidimensional factor structure. Furthermore, the COBRA‐TR successfully differentiated patients from controls. Clinical variables minimally influenced the scale, though it showed weak correlations with subclinical depressive symptoms ( r = 0.325; p = 0.003) and working memory performance ( r = −0.250; p = 0.002).
Conclusion
Our findings highlight that the COBRA‐TR is a highly reliable and valid tool, effectively capturing SCC among BD patients. Its brevity, ease of administration, and strong psychometric properties suggest its potential utility as a valuable instrument in both clinical practice and research settings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychiatry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Psychiatry, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye.
- Cekmekoy Community Mental Health Center, Istanbul Erenkoy Training and Research Hospital for Mental and Nervous Disorders, Istanbul, Türkiye.
- Department of Psychiatry, Faculty of Medicine, Bahcesehir University, Istanbul, Türkiye.
ORCID profiles: Ezgi Ince Guliyev
Cite
APA
Ince Guliyev, E., Karaca Ozkutuk, G., Cagal, S., Ozturk, E. O., Elik, T., Akdas, N., Horasan, C., Cakır, S., Direk, N., & Aydemir, O. (2025). The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment. International Journal of Methods in Psychiatric Research. https://doi.org/10.1002/mpr.70037
Vancouver
Ince Guliyev E, Karaca Ozkutuk G, Cagal S, Ozturk EO, Elik T, Akdas N, et al. The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment. International Journal of Methods in Psychiatric Research. 2025. doi:10.1002/mpr.70037
BibTeX
@article{InceGuliyev2025,
author = {Ince Guliyev, Ezgi and Karaca Ozkutuk, Gulcan and Cagal, Sema and Ozturk, Ece Ozlem and Elik, Tugay and Akdas, Nupelda and Horasan, Cem and Cakır, Sibel and Direk, Nese and Aydemir, Omer},
title = {The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment},
journal = {International Journal of Methods in Psychiatric Research},
year = {2025},
doi = {10.1002/mpr.70037}
}
EUVIMED